Clinical Trial Update: Open-Label Extension Study of Recombinant Human Arylsulfatase A (HGT-1111) in Late Infantile MLD [Phase 2]

View source ↗

Summary

Phase 2 open-label extension trial for recombinant human arylsulfatase A (HGT-1111) in late infantile metachromatic leukodystrophy has terminated with posted re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infantile Metachromatic Leukodystrophy

Drugs mentioned

• recombinant human arylsulfatase A (HGT-1111) (aryl sulfatase A)

Snippet

Sponsor: Shire | Conditions: Late Infantile Metachromatic Leukodystrophy | Phase 2 | Status: TERMINATED | Results posted: 2013-11-08